Women's Health

As the first dual neurokinin-1 and 3 receptor antagonist, elinzanetant could provide benefit for women suffering from vasomotor symptoms.

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.

Women were also more likely to report concerns of high wait times prior to receiving care.

Patients in persistently impoverished areas were also more likely to have more aggressive tumor characteristics and receive more invasive surgeries.

The findings support current recommendations for pregnant individuals or those who might become pregnant during the influenza season, specifically those with successive pregnancies.

The work of Obstetrician Ignaz Semmelweis lives on in medical protocols today.

About 72% of the observed pregnancies after allogeneic hematopoietic cell transplantation occurred spontaneously, whereas remaining pregnancies were a result of assisted reproductive activities.

Investigators reported that more than half of individuals had great knowledge about protecting themselves from COVID-19.

The researchers estimate that pregnancy losses because of malaria and parasitemia risk before conception was reduced by 65% to 86%.

The authors also found that there was a higher frequency of miscarriages compared with women who did not have asthma.

Additionally, the authors are concerned by the lack of increase in depressive or anxiety diagnoses, indicating potential barriers to care.

Pharmacists’ role in community-based cancer centers are expanding, with a more significant role in treatment plan selection, education, collaboration to create individualized care plans, managing adverse effects, and aiding with financial toxicities.

The study authors suggest that annual screening for women aged 40 and older may be beneficial, but warn of the increased risk of false positive results.

There is no significant impact on maternal or infant health outcomes when taking an additional iron supplement

Intravenous immunoglobulin (IVIG) therapy was found to have statistically significant positive effects on live birth rates, implantation rate, and other indicators.

The authors stress that health care providers should explain false positive results to their patients, reassure them that results may be negative, and stress the significance of continued screenings.

For those with unexplained pregnancy loss, these results could prove promising improvements to birth outcomes.

Women's health extends beyond reproductive health, yet much of the research in women's health focuses on these "below the belt" health issues, despite data showing that women disproportionately suffer from certain health conditions, such as heart failure.

The author suggest how to improve the representation of women, older adults, and minorities in clinical research that will require effort from a broad range of stakeholders.

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.

Nurx reproductive access survey reveals 28% of women do not believe their right to contraception is protected.

The updates are based on nationwide reports of extreme pain during IUD insertion.

Pharmacists play an important role in managing patients with this complex condition.

Investigators will examine the combination with pembrolizumab and lenvatinib in patients with HER2-expressing endometrial cancer.

The RUBY trial will continue and analyze the overall population survival after treatment with the drug combination.